MedTrace Logo

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma

NCT02555267 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2023-02-03

No results posted yet for this study

Summary

This study investigate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity index (CCI) on survival and toxicities in Korean patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.

Conditions

  • Lymphoma, Large B-cell, Diffuse

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Kyungpook National University Hospital

    collaborator OTHER

  • Keimyung University Dongsan Medical Center

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • Kosin University Gospel Hospital

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • Soonchunhyang University Hospital

    collaborator OTHER

  • Ajou University School of Medicine

    collaborator OTHER

  • Chonnam National University Hospital

    collaborator OTHER

  • Chonbuk National University Hospital

    lead OTHER

Principal Investigators

  • Ho-Young Yhim, MD, PhD · Chonbuk National University Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-07-31
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02555267 on ClinicalTrials.gov